CtBP CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. CtBP Gen Silencer sind erhältlich als CtBP CRISPR/Cas9 Knockout Plasmide und CtBP Double Nickase Plasmide. CtBP CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
CtBP CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
CtBP1 CRISPR/Cas9 KO Plasmid (h) | sc-400667 | h | Gene Knockout | GFP | 0 | ||
CtBP1 HDR Plasmid (h) | sc-400667-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
CtBP1 Double Nickase Plasmid (h) | sc-400667-NIC | h | Gene Knockout | Puromycin | 0 | ||
CtBP1 Double Nickase Plasmid (h2) | sc-400667-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
CtBP1 CRISPR/Cas9 KO Plasmid (m) | sc-419867 | m | Gene Knockout | GFP | 0 | ||
CtBP1 HDR Plasmid (m) | sc-419867-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
CtBP1 Double Nickase Plasmid (m) | sc-419867-NIC | m | Gene Knockout | Puromycin | 0 | ||
CtBP1 Double Nickase Plasmid (m2) | sc-419867-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
CtBP2 CRISPR/Cas9 KO Plasmid (h) | sc-401865 | h | Gene Knockout | GFP | 0 | ||
CtBP2 HDR Plasmid (h) | sc-401865-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
CtBP2 Double Nickase Plasmid (h) | sc-401865-NIC | h | Gene Knockout | Puromycin | 0 | ||
CtBP2 Double Nickase Plasmid (h2) | sc-401865-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
CtBP2 CRISPR/Cas9 KO Plasmid (m) | sc-419868 | m | Gene Knockout | GFP | 0 | ||
CtBP2 HDR Plasmid (m) | sc-419868-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
CtBP2 Double Nickase Plasmid (m) | sc-419868-NIC | m | Gene Knockout | Puromycin | 0 | ||
CtBP2 Double Nickase Plasmid (m2) | sc-419868-NIC-2 | m | Gene Knockout | Puromycin | 0 |
CtBP CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
CtBP1 CRISPR Activation Plasmid (h) | sc-400667-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CtBP1 CRISPR Activation Plasmid (h2) | sc-400667-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CtBP1 Lentiviral Activation Particles (h) | sc-400667-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CtBP1 Lentiviral Activation Particles (h2) | sc-400667-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CtBP1 CRISPR Activation Plasmid (m) | sc-419867-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CtBP1 CRISPR Activation Plasmid (m2) | sc-419867-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CtBP1 Lentiviral Activation Particles (m) | sc-419867-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CtBP1 Lentiviral Activation Particles (m2) | sc-419867-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CtBP2 CRISPR Activation Plasmid (h) | sc-401865-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CtBP2 CRISPR Activation Plasmid (h2) | sc-401865-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CtBP2 Lentiviral Activation Particles (h) | sc-401865-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CtBP2 Lentiviral Activation Particles (h2) | sc-401865-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CtBP2 CRISPR Activation Plasmid (m) | sc-419868-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CtBP2 CRISPR Activation Plasmid (m2) | sc-419868-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CtBP2 Lentiviral Activation Particles (m) | sc-419868-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
CtBP2 Lentiviral Activation Particles (m2) | sc-419868-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |